Search Results 61-70 of 16731 for GLP-1 agonists
Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes · Overview · Participation eligibility · Participating Mayo Clinic locations.
... 1 trial. Phase 4 trials look at long-term safety and effectiveness ... Current or planned use of glucose lowering medication, including GLP-1 agonists ...
Newer drugs include Metformin (Fortamet, Glumetza, others), glucagon-like peptide 1 (GLP-1) receptor agonists and SGLT2 inhibitors. Ask your health care ...
... glucagon-like peptide-1 receptor agonist use. Dis Esophagus. 2025 Nov 1; 38 (6) View PubMed; Marek G. Not so subclinical: Is early thyroid disease an ...
However, safety and efficacy of glucagon nasal powder have not been established in children younger than 1 year of age. Geriatric. Appropriate studies performed ...
... GLP-1 agonists used for diabetes and tricyclic antidepressants at high doses), neurological disorders, and autoimmune disorders. Published in 2021, the ...
Obesity, polycystic ovary syndrome, and infertility: A new avenue for GLP-1 receptor agonists. Journal of Clinical Endocrinology and Metabolism. 2020; doi ...
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database. Diagnostics (Basel) ...
Both type 1 and type 2 diabetes can begin during childhood and adulthood. Type 2 is more common in older adults. But the increase in the number of children ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.